STXS
Stereotaxis·AMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 1
Consensus Rating "Strong Buy"
High Gross Profit Margin
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About STXS
Stereotaxis, Inc.
A pioneer and global leader in surgical robotics for minimally invasive endovascular intervention
Healthcare Equipment and Supplies
--
09/06/2019
American Stock Exchange
139
12-31
Common stock
710 North Tucker Boulevard, Suite 110, St. Louis, MO 63101
--
Stereotaxis, Inc., was incorporated in Delaware in June 1990. The company is a pioneer and global leader in the field of minimally invasive endovascular interventional surgical robots. The company designs, manufactures and sells robotic systems, instruments and information systems for interventional laboratories. The company's proprietary robotics technology, robotic magnetic navigation, fundamentally alters endovascular intervention, using precise computer-controlled magnetic fields to directly control the tip of a flexible interventional catheter or device. Directly controlling the tip of the intervention device, unlike all manual handheld devices controlled from the handle, improves the accuracy, stability, antennae and safety of these devices during operation. The company's primary clinical focus has been electrophysiology, specifically cardiac ablation surgery for the treatment of arrhythmias.
Earnings Call
Q1/2025
Estimate EPS-0.07
Actual EPS-0.07
Estimate Revenue6.88M
Actual Revenue7.47M
Navigating Contradictions: MAGiC Catheter's U.S. Adoption Timeline and Market Potential Unveiled
May 20,2025 09:03
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS-0.06
Actual EPS-0.07
Estimate Revenue8.38M
Actual Revenue7.46M
Stereotaxis Q3 2025: Contradictions Emerge on Commercial Team Expansion, MAGiC RF Adoption, and Revenue Forecasts
Nov 11,2025 08:08
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
STXS has released its 2025 Q3 earnings. EPS was reported at -0.07, versus the expected -0.06, missing expectations. The chart below visualizes how STXS has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
STXS has released its 2025 Q3 earnings report, with revenue of 7.46M, reflecting a YoY change of -18.83%, and net profit of -6.46M, showing a YoY change of -4.41%. The Sankey diagram below clearly presents STXS's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
